Login / Signup

Cognitive performance and lifetime cannabis use in patients with first-episode schizophrenia spectrum disorder.

M HájkováKarolina KnížkováA SiroňováBarbora KeřkováJuraj JonášP ŠustováA DorazilováM Rodriguez
Published in: Cognitive neuropsychiatry (2021)
The results delivered supporting evidence for the trend of superior neurocognitive performance in FES patients with a lifetime history of cannabis use compared to non-using patients.
Keyphrases
  • end stage renal disease
  • spectrum disorder
  • bipolar disorder
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • peritoneal dialysis
  • prognostic factors